We think it is key to first focus our services and energy on the very specific oncology application. We will then extend and open our services to other chronicle diseases such as diabetes.

In parallel, we further wish to enhance our applicative richness and user interface. Our ability to target specific urine components for personalised monitoring will lead to the opening of further facilities.

Finally, all on-going and already developed services and specific applications will contribute to building our urine database, thus providing added value for further research and embedded data services.